Purpose Prostate-specific antigen (PSA) density (PSAD) has potential to increase the
diagnostic utility of PSA, yet has had poor uptake in clinical practice. We aimed to determine …

Tremendous technological advancements in prostate radiotherapy have decreased
treatment toxicity and improved clinical outcomes for men with prostate cancer. While these …

Prostate magnetic resonance imaging (MRI) stands as the cornerstone in diagnosing
prostate cancer (PCa), offering superior detection capabilities while minimizing unnecessary …

Purpose There is not yet satisfactory performance data comparing multiparametric MRI
(mpMRI) versus biparametric MRI (bpMRI) for detecting prostate cancer (PCa), particularly in …

Background Prostate imaging reporting and data system version 2 (PI-RADS v2) relegates
dynamic contrast enhanced (DCE) imaging to a minor role. We sought to determine how …

This research is to develop a new tool to improve the performance of predicting prostate
cancer (PCa) and reducing unnecessary biopsies. The clinical data of patients who were …

Several advances in the imaging of PCa have been made during the past year. In particular,
important clinical developments have been reported in multiparametric MRI, PET/computed …

The diagnosis and treatment of prostate cancer continue to evolve with advances in science
and technology. The utilization of multiparametric MRI (mp-MRI) to identify lesions in the …

Background Multiparametric magnetic resonance imaging (mpMRI) can improve detection of
clinically significant prostate cancer (csPCa). Purpose To compare mpMRI score subgroups …

Background Only limited data have been published on the diagnostic accuracy of combining
biparametric (bp) magnetic resonance imaging (MRI) and prostate-specific antigen density …